CMS ACCESS tests outcome-aligned payment for technology-supported chronic care in Original Medicare.
Last verified 2026-08-08 · Fingerprint a50c3c7ea6ba91ba
Public Proof Ledger
Inspect the claim, source, status and version.
Sourced facts and P4L inferences are recorded separately, with stable claim IDs, verification dates, fingerprints and correction state.
CMS reported more than 150 organizations accepted to participate in ACCESS.
Last verified 2026-08-08 · Fingerprint 2cd2d587ee9aec96
FDA's TEMPO participant table lists Cadence Solutions' HypertensionOS and Dexcom's Glucose Health Program.
Last verified 2026-08-08 · Fingerprint d40e94452290ba9d
ACCESS + TEMPO creates a practical bridge among payment, regulatory oversight, real-world evidence, and technology-supported chronic care.
Last verified 2026-08-08 · Fingerprint 998fcea1f430bfcb
CMS's Medicare App Library explicitly includes Conversational AI Assistants and Diabetes & Obesity Prevention and Management among supported app use cases.
Last verified 2026-08-08 · Fingerprint 52676abc5eeed191
The CMS interoperability framework says numerous Health Tech Ecosystem early adopters reached general availability in July 2026.
Last verified 2026-08-08 · Fingerprint 252500549947ac7e
ASTP/ONC approved USCDI v6 through the 2026 SVAP process.
Last verified 2026-08-08 · Fingerprint 24028b4f8660f32e
FDA opened a July–August 2026 funding opportunity to study DHTs including actigraphy, photography, and contactless sensors in drug development.
Last verified 2026-08-08 · Fingerprint 30e22e9710047075
FDA announced real-time clinical-trial proofs of concept using AI and data science.
Last verified 2026-08-08 · Fingerprint 6f090de245b1448c
ARPA-H ADVOCATE is intended to develop clinical agentic AI for cardiovascular care plus a supervisory AI overseer.
Last verified 2026-08-08 · Fingerprint 87af819712398eaf
ARPA-H IGoR aims to build AI-enabled research ecosystems that accelerate biological discovery by at least 10× versus traditional approaches.
Last verified 2026-08-08 · Fingerprint b3c956f9b4a91419
ARPA-H PROSPR funds seven teams and up to $144 million to develop healthspan measures and accelerated trials.
Last verified 2026-08-08 · Fingerprint 3943f1e4f34f0aef
PROSPR THRIVE is developing and testing a PROSPR-IC healthspan score from harmonized longitudinal data.
Last verified 2026-08-08 · Fingerprint 8b6b86502a007e95
PROSPR VITAL-H plans a phase 3 hybrid trial of repurposed drugs to establish a regulatory path for testing therapeutics for aging.
Last verified 2026-08-08 · Fingerprint 2e653dfbeaf3bb09
ARPA-H awarded Linnaeus Therapeutics up to $21.9 million to test a GPER agonist for aging outcomes.
Last verified 2026-08-08 · Fingerprint b94b3f8f37ce3218
CMS's CY 2027 PFS proposal includes material proposed changes to RPM/RTM delivery and payment requirements.
Last verified 2026-08-08 · Fingerprint ef1cd0d200f17c94
CMS highlighted OIG findings that about 43% of Medicare RPM enrollees did not receive all three components.
Last verified 2026-08-08 · Fingerprint 878ba364c6f2dc28
FDA says CDER has seen significant growth in drug submissions using AI components across the product lifecycle.
Last verified 2026-08-08 · Fingerprint 8a9b964edc69e6ba
ASTP/ONC's HTI-5 proposal explicitly discusses automated access to EHI and potentially autonomous AI systems.
Last verified 2026-08-08 · Fingerprint 8fc464c1954014d6
A validated, intervention-responsive healthspan score could materially alter trial design, product claims, evidence generation, and reimbursement strategy.
Last verified 2026-08-08 · Fingerprint 6f383994949db054